NO20053341D0 - Hindring og behandling av Alzheimers sykdom. - Google Patents

Hindring og behandling av Alzheimers sykdom.

Info

Publication number: NO20053341D0
Authority: NO; Norway
Prior art keywords: alzheimer; disease; prevention; treatment
Prior art date: 2002-12-12

Application number

NO20053341A

Other languages

English (en)

Other versions

NO20053341L (no

Inventor

Hubert Heuer

Laurent Pradier

Hans-Ludwig Schaefer

Thierry Canton

Jesus Benavides

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-12

Filing date

2005-07-08

Publication date

2005-07-08

2005-07-08 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2005-07-08 Publication of NO20053341D0 publication Critical patent/NO20053341D0/no

2005-09-07 Publication of NO20053341L publication Critical patent/NO20053341L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

NO20053341A 2002-12-12 2005-07-08 Hindring og behandling av Alzheimers sykdom. NO20053341L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0215722A FR2848452B1 (fr)	2002-12-12	2002-12-12	Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer
PCT/FR2003/003654 WO2004062652A1 (fr)	2002-12-12	2003-12-10	Application et traitement de la maladie d'alzheimer

Publications (2)

Publication Number	Publication Date
NO20053341D0 true NO20053341D0 (no)	2005-07-08
NO20053341L NO20053341L (no)	2005-09-07

Family

ID=32338722

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053341A NO20053341L (no)	2002-12-12	2005-07-08	Hindring og behandling av Alzheimers sykdom.

Country Status (22)

Country	Link
EP (1)	EP1572174A1 (no)
JP (1)	JP2006514063A (no)
KR (1)	KR20050084250A (no)
CN (1)	CN1726016A (no)
AR (1)	AR042354A1 (no)
AU (1)	AU2003296802A1 (no)
BR (1)	BR0317280A (no)
CA (1)	CA2507945A1 (no)
CO (1)	CO5700712A2 (no)
FR (1)	FR2848452B1 (no)
HR (1)	HRP20050534A2 (no)
MA (1)	MA27500A1 (no)
MX (1)	MXPA05005556A (no)
NO (1)	NO20053341L (no)
NZ (1)	NZ540496A (no)
PE (1)	PE20040770A1 (no)
PL (1)	PL377110A1 (no)
RS (1)	RS20050420A (no)
RU (1)	RU2005121909A (no)
TW (1)	TW200503707A (no)
WO (1)	WO2004062652A1 (no)
ZA (1)	ZA200504656B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7521481B2 (en)	2003-02-27	2009-04-21	Mclaurin Joanne	Methods of preventing, treating and diagnosing disorders of protein aggregation
AU2004290499C1 (en)	2003-11-03	2011-02-24	Probiodrug Ag	Combinations useful for the treatment of neuronal disorders
CA2554809C (en)	2004-02-05	2014-04-29	Probiodrug Ag	Novel n-alkyl thiourea- and thioamide-substituted imidazolyl inhibitors of glutaminyl cyclase
CA2589102C (en)	2004-11-02	2013-08-13	Northwestern University	Pyridazine compounds and methods for using the compounds to treat inflammatory diseases
EP2015750A2 (en)	2006-04-28	2009-01-21	Northwestern University	Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
MX2009012583A (es) *	2007-05-22	2010-03-08	Otsuka Pharma Co Ltd	Un medicamento que comprende un derivado de carbostirilo y donepezilo para tratar enfermedad de alzheimer.
US20140243281A1 (en) *	2011-10-28	2014-08-28	Lumena Pharmaceuticals, Inc.	Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
EP2770990A4 (en)	2011-10-28	2015-03-11	Lumena Pharmaceuticals Inc	Gallic acid refluxing agent for the treatment of hypertension and chronic liver disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2040996A1 (en) *	1990-05-02	1991-11-03	Robert L. Albright	Composition and method for controlling cholesterol
ATE231723T1 (de) *	1991-02-22	2003-02-15	Howard K Shapiro	Verwendung von pharmazeutischen wirkstoffen zur behandlung von krankheitssymptomen neurologischer erkrankungen und etiologisch verwandter symptomenkomplexe
WO1997049736A2 (en) *	1996-06-27	1997-12-31	G.D. Searle And Co.	Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
US5985936A (en) *	1997-12-18	1999-11-16	Forbes Medi-Tech, Inc.	Method of preventing and delaying onset of Alzheimer's disease and composition therefor
CA2311356C (en) *	1998-01-28	2004-07-13	Warner-Lambert Company	Method for treating alzheimer's disease
US6080778A (en) *	1998-03-23	2000-06-27	Children's Medical Center Corporation	Methods for decreasing beta amyloid protein
US6221897B1 (en) *	1998-06-10	2001-04-24	Aventis Pharma Deutschland Gmbh	Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19825804C2 (de) *	1998-06-10	2000-08-24	Aventis Pharma Gmbh	1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19845405C2 (de) *	1998-10-02	2000-07-13	Aventis Pharma Gmbh	Arylsubstituierte Propanolaminderivate und deren Verwendung
AU2001233299A1 (en) *	2000-02-04	2001-08-14	Esperion Therapeutics Inc.	Methods for treating alzheimer's disease
US20020028826A1 (en) *	2000-06-15	2002-03-07	Robl Jeffrey A.	HMG-CoA reductase inhibitors and method
SE0104334D0 (sv) *	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents
TWI329111B (en) *	2002-05-24	2010-08-21	X Ceptor Therapeutics Inc	Azepinoindole and pyridoindole derivatives as pharmaceutical agents

2002
- 2002-12-12 FR FR0215722A patent/FR2848452B1/fr not_active Expired - Fee Related
2003
- 2003-12-10 KR KR1020057010595A patent/KR20050084250A/ko not_active Application Discontinuation
- 2003-12-10 RU RU2005121909/15A patent/RU2005121909A/ru not_active Application Discontinuation
- 2003-12-10 WO PCT/FR2003/003654 patent/WO2004062652A1/fr active Application Filing
- 2003-12-10 NZ NZ540496A patent/NZ540496A/en unknown
- 2003-12-10 AR ARP030104540A patent/AR042354A1/es not_active Application Discontinuation
- 2003-12-10 CA CA002507945A patent/CA2507945A1/fr not_active Abandoned
- 2003-12-10 PL PL377110A patent/PL377110A1/pl not_active Application Discontinuation
- 2003-12-10 JP JP2004566119A patent/JP2006514063A/ja not_active Abandoned
- 2003-12-10 AU AU2003296802A patent/AU2003296802A1/en not_active Abandoned
- 2003-12-10 EP EP03815109A patent/EP1572174A1/fr not_active Withdrawn
- 2003-12-10 CN CNA2003801059727A patent/CN1726016A/zh active Pending
- 2003-12-10 BR BR0317280-5A patent/BR0317280A/pt not_active IP Right Cessation
- 2003-12-10 RS YUP-2005/0420A patent/RS20050420A/sr unknown
- 2003-12-10 PE PE2003001247A patent/PE20040770A1/es not_active Application Discontinuation
- 2003-12-10 MX MXPA05005556A patent/MXPA05005556A/es not_active Application Discontinuation
- 2003-12-11 TW TW092134949A patent/TW200503707A/zh unknown
2005
- 2005-06-07 ZA ZA200504656A patent/ZA200504656B/en unknown
- 2005-06-09 CO CO05056010A patent/CO5700712A2/es not_active Application Discontinuation
- 2005-06-10 MA MA28329A patent/MA27500A1/fr unknown
- 2005-06-10 HR HR20050534A patent/HRP20050534A2/xx not_active Application Discontinuation
- 2005-07-08 NO NO20053341A patent/NO20053341L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2004062652A1 (fr)	2004-07-29
BR0317280A (pt)	2005-11-08
PL377110A1 (pl)	2006-01-23
AR042354A1 (es)	2005-06-15
AU2003296802A1 (en)	2004-08-10
MXPA05005556A (es)	2005-07-26
PE20040770A1 (es)	2004-12-10
MA27500A1 (fr)	2005-08-01
ZA200504656B (en)	2006-08-30
NO20053341L (no)	2005-09-07
RS20050420A (en)	2007-04-10
RU2005121909A (ru)	2006-01-20
JP2006514063A (ja)	2006-04-27
CN1726016A (zh)	2006-01-25
TW200503707A (en)	2005-02-01
FR2848452A1 (fr)	2004-06-18
EP1572174A1 (fr)	2005-09-14
CO5700712A2 (es)	2006-11-30
CA2507945A1 (fr)	2004-07-29
FR2848452B1 (fr)	2007-04-06
HRP20050534A2 (en)	2006-11-30
KR20050084250A (ko)	2005-08-26
NZ540496A (en)	2008-04-30

Publication	Publication Date	Title
DK1303272T3 (da)	2008-05-26	Benzothiazolderivater til behandling af Alzheimers sygdom og Parkinsons sygdom
NO20022531D0 (no)	2002-05-28	Vaksine for forebyggelse og behandling av Alzheimer og amyloidrelaterte sykdommer
DK1392287T3 (da)	2007-03-19	Anvendelse af substituerede azetidinonderivater i behandlingen af Alzheimers sygdom
NO20015773D0 (no)	2001-11-27	Forhindring og behandling av amyloidogen sykdom
GB0223040D0 (en)	2002-11-13	Therapeutic compounds
DK1765388T3 (da)	2013-07-22	Kombinationsterapi til forebyggelse eller behandling af alzheimer's sygdom, og kit dertil
ATE350375T1 (de)	2007-01-15	17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
AU2003220096A8 (en)	2003-09-22	Methods for alzheimer's disease treatment and cognitive enhancement
AU2003226014A8 (en)	2003-10-13	Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease
GB0117645D0 (en)	2001-09-12	Therapeutic stratergies for prevention and treatment of alzheimers disease
DK2527315T3 (da)	2014-06-02	Forbindelser, præparater og fremgangsmåder til behandling af amyloide sygdomme og synukleinopatier, såsom Alzheimers sygdom, type 2-diabetes og Parkinsons sygdom
EP1578253A4 (en)	2008-11-12	PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASE
NO20044195L (no)	2004-10-01	Biofosfoninsyrer for behandling og prevensjon av osteoprose
NO20041882L (no)	2004-05-07	Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
NO20053855D0 (no)	2005-08-18	1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
NO20034855D0 (no)	2003-10-30	Behandling og diagnose av makrofagmediert sykdom
AU2003206413A8 (en)	2003-07-24	Substituted amino carboxamides for the treatment of alzheimer's disease
IS8135A (is)	2005-11-21	Þríhringtengdar indólafleiður og notkun þeirra til að meðhöndla Alzheimers-sjúkdóm
EP1489915A4 (en)	2005-09-14	TREATMENT AND PREVENTION OF INFLAMMATORY DISORDERS
AU2003273213A8 (en)	2003-12-19	Amyloid peptide inactivating enzyme to treat alzheimer's disease
AU2003231252A1 (en)	2003-11-11	Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease
DK2380583T3 (da)	2013-12-02	Små peptider til behandling af Alzheimers sygdom og andre beta-amyloidprotein-fibrillogeneseforstyrrelser
NO20054714D0 (no)	2005-10-13	Fremgangsmate for behandling av svake kognitive svekkelser, og for a forhindre eller utsette Alzheimers sykdom
IS6967A (is)	2003-09-24	Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
NO20053341D0 (no)	2005-07-08	Hindring og behandling av Alzheimers sykdom.

Legal Events

Date	Code	Title	Description
2009-07-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application